Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...

Additional data presented at ASCO highlights Libtayo’s ability to hold off recurrence of a type of skin cancer.

Adjuvant cemiplimab (Libtayo) significantly improved disease-free survival (DFS) compared with placebo in patients at high ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Skin cancer is often under-recognised in India, especially around the eyes. Here are some key facts everyone should know ...

Surgery is the go-to treatment for cutaneous squamous cell ... cancer. During the surgery, you’ll be awake while the surgeon removes a very thin layer of skin tissue and examines it under ...

Julie Brahmer, MD, director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ... and do tend to do better than those ...

“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell ... needs in cancer care; and BeiGene’s plans, commitments, aspirations, and goals under the heading ...

Have a history of skin cancer. If you’ve had any other types of cancer, like basal cell or squamous cell carcinoma ... you can lower your risk. Keep an eye out for skin changes.

2D, two dimensional radiotherapy; 3D, three dimensional radiotherapy; IMRT, intensity-modulated radiotherapy; OS, overall survival; NPC, nasopharyngeal carcinoma; HNSCC, head and neck squamous cell ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma ... studied skin biopsies under the microscope to understand the drug's ...

Checkpoint Therapeutics, Inc. announced that the FDA has approved UNLOXCYT™ (cosibelimab-ipdl) for treating adults with metastatic cutaneous squamous cell carcinoma ... as the eye or ear.